Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ensereptide - ProMore Pharma

Next Previous
X
Search
Drug Profile

Ensereptide - ProMore Pharma

Alternative Names: PXL-01

Latest Information Update: 25 Apr 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PharmaSurgics
  • Developer PharmaSurgics; ProMore Pharma; Technomark Life Sciences
  • Class Glycoproteins; Peptides
  • Mechanism of Action Interleukin 1 beta inhibitors; Interleukin 6 inhibitors; Interleukin 8 inhibitors; Plasminogen activator inhibitor-1 inhibitors; Tumour necrosis factor alpha inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Post-surgical adhesions

Highest Development Phases

  • Phase III Post-surgical adhesions

Most Recent Events

  • 20 Apr 2023 Adverse events and efficacy data from the phase II PHSU05 trial in Post-surgical adhesions (Prevention) released by ProMore Pharma
  • 20 Apr 2023 ProMore Pharma completes the phase II PHSU05 trial in Post-surgical adhesions (Prevention)
  • 20 Apr 2023 ProMore Pharma initiates the phase II PHSU05 trial in Post-surgical adhesions (Prevention) before April 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top